Updated ESC/EACTS Guidelines Mark Advancement in Structural Heart Disease Care
Go back to Updated ESC/EACTS Guidelines Mark Advancement in Structural Heart Disease Care| Edwards Lifesciences (NYSE: EW) | Delayed: 92.21 +0.88 (0.96%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $91.33 | 52 Week High | $166.87 | |||
| Open | $91.70 | 52 Week Low | $72.20 | |||
| Day High | $92.25 | P/E | 26.81 | |||
| Day Low | $90.69 | EPS | $3.44 | |||
| Volume | 3,381,397 | |||||
